SCHEMBL8010677

SCHEMBL8010677

COc1cc(-c2nc3ccccc3n2Cc2ccccc2I)cc(OC)c1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.56
HTT P42858 4/20 0.56
LMNA P02545 4/20 0.56
NPSR1 Q6W5P4 3/20 0.56
GAA P10253 4/20 0.53
ALDH1A1 P00352 5/20 0.52
TP53 P04637 4/20 0.52
HSD17B10 Q99714 2/20 0.52
HPGD P15428 2/20 0.52
NPC1 O15118 1/20 0.52
MAPK1 P28482 1/20 0.52
RAB9A P51151 1/20 0.52
RECQL P46063 1/20 0.50
SMN1; SMN2 Q16637 7/20 0.48
MAPT P10636 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8021478 0.90 KDM4E (0.70) KDM4EHTTLMNANPSR1GAA
SCHEMBL8024179 0.88 KDM4E (0.58) KDM4EHTTLMNANPSR1GAA
SCHEMBL8021964 0.86 TP53 (0.66) KDM4EHTTLMNANPSR1GAA
SCHEMBL8024166 0.86 KDM4E (0.56) KDM4EHTTLMNANPSR1GAA
SCHEMBL8023335 0.86 KDM4E (0.56) KDM4EHTTLMNANPSR1GAA
SCHEMBL8024183 0.84 KDM4E (0.53) KDM4EHTTLMNANPSR1GAA
SCHEMBL8021582 0.83 ALDH1A1 (0.67) KDM4EHTTLMNANPSR1GAA
SCHEMBL8023384 0.81 KDM4E (0.69) KDM4EHTTLMNANPSR1GAA
SCHEMBL8023183 0.81 NPSR1 (0.57) KDM4EHTTLMNANPSR1GAA
SCHEMBL8022079 0.81 KDM4E (0.76) KDM4EHTTLMNANPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030992-A ANTAGONISTS FOR THE BINDING OF NEUROKININ-2 RECEPTOR; SLEEP DISORDERS; BENZIMIDES, 2- OR 3-ALKOXYBENZIMIDES AND 2,3-DIALKOXYBENZIMIDES ELI LILLY AND COMPANY (US) 2000-02-29 US disclosed
US-6025379-A A SUBSTITUTED BENZIMIDAZOLE, TACHYKININ RECEPTOR ANTAGONISTS, ELI LILLY AND COMPANY (US) 2000-02-15 US disclosed
WO-1997031635-A1 METHODS OF TREATING OR PREVENTING SLEEP APNEA ELI LILLY AND COMPANY (US) 1997-09-04 WO disclosed
US-5552426-A NERVOUS SYSTEM DISORDERS USING IMIDAZOLE DERIVITIVES ELI LILLY AND COMPANY (US) 1996-09-03 US disclosed
EP-0694535-A1 Non-peptidyl tachykinin receptor antagonists ELI LILLY AND COMPANY (US) 1996-01-31 EP disclosed